1. Home
  2. MBIO vs LDWY Comparison

MBIO vs LDWY Comparison

Compare MBIO & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • LDWY
  • Stock Information
  • Founded
  • MBIO 2015
  • LDWY 1990
  • Country
  • MBIO United States
  • LDWY United States
  • Employees
  • MBIO N/A
  • LDWY N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • LDWY Advertising
  • Sector
  • MBIO Health Care
  • LDWY Consumer Discretionary
  • Exchange
  • MBIO Nasdaq
  • LDWY Nasdaq
  • Market Cap
  • MBIO 7.3M
  • LDWY 8.2M
  • IPO Year
  • MBIO N/A
  • LDWY 1991
  • Fundamental
  • Price
  • MBIO $2.92
  • LDWY $4.34
  • Analyst Decision
  • MBIO Strong Buy
  • LDWY
  • Analyst Count
  • MBIO 1
  • LDWY 0
  • Target Price
  • MBIO $100.00
  • LDWY N/A
  • AVG Volume (30 Days)
  • MBIO 426.8K
  • LDWY 5.6K
  • Earning Date
  • MBIO 03-10-2025
  • LDWY 03-31-2025
  • Dividend Yield
  • MBIO N/A
  • LDWY N/A
  • EPS Growth
  • MBIO N/A
  • LDWY N/A
  • EPS
  • MBIO N/A
  • LDWY N/A
  • Revenue
  • MBIO N/A
  • LDWY $31,581,000.00
  • Revenue This Year
  • MBIO N/A
  • LDWY N/A
  • Revenue Next Year
  • MBIO N/A
  • LDWY N/A
  • P/E Ratio
  • MBIO N/A
  • LDWY N/A
  • Revenue Growth
  • MBIO N/A
  • LDWY N/A
  • 52 Week Low
  • MBIO $2.81
  • LDWY $3.02
  • 52 Week High
  • MBIO $74.50
  • LDWY $6.88
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 28.00
  • LDWY 47.81
  • Support Level
  • MBIO $3.96
  • LDWY $4.13
  • Resistance Level
  • MBIO $6.70
  • LDWY $4.55
  • Average True Range (ATR)
  • MBIO 0.97
  • LDWY 0.22
  • MACD
  • MBIO -0.12
  • LDWY -0.02
  • Stochastic Oscillator
  • MBIO 2.83
  • LDWY 39.98

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About LDWY Lendway Inc. (DE)

Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.

Share on Social Networks: